Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology

What problem does this paper attempt to address?

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression

Kuanhou Mou,Xiang Zhang,Xin Mu,Rui Ge,Dan Han,Yan Zhou,Li-Juan Wang

DOI: https://doi.org/10.3389/fonc.2022.905360

IF: 4.7

2022-05-10

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00569.].

oncology
Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Jinguo Zhang,Benjie Shan,Lin Lin,Jie Dong,Qingqing Sun,Qiong Zhou,Jian Chen,Xinghua Han

DOI: https://doi.org/10.3389/fcell.2021.812770

IF: 5.5

2021-12-09

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.711859.].

cell biology,developmental biology
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Yongmeng Li,Yanfei Liu,Kai Jin,Rui Dong,Cun Gao,Libo Si,Zitong Feng,Huiying Zhang,Hui Tian

DOI: https://doi.org/10.3389/fcell.2022.870313

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.771824.].
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing

Wenli Mao,Qingzhen Yu,Kefeng Wang,Qiang Ma,Yuxin Zheng,Guojun Zhang,Wei Luo,Nianwu Wang,Yukun Wang

DOI: https://doi.org/10.3389/fonc.2022.1032295

IF: 4.7

2022-10-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.791332.].

oncology
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology
Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Fang Tong,Lifa Xu,Sheng Xu,Mingming Zhang

DOI: https://doi.org/10.3389/fgene.2022.1050296

IF: 3.7

2022-10-25

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.834935.].

genetics & heredity
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Xi Chen,Jishu Guo,Fan Zhou,Wenjun Ren,Xiaobin Huang,Jun Pu,Xiaoqun Niu,Xiulin Jiang

DOI: https://doi.org/10.3389/fonc.2024.1223478

IF: 4.7

2024-09-04

Frontiers in Oncology

Abstract:This article is a correction to: Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

oncology
Corrigendum: Cuproptosis Key Gene FDX1 is a Prognostic Biomarker and Associated with Immune Infiltration in Glioma.

Hanwen Lu,Liwei Zhou,Bingchang Zhang,Yuanyuan Xie,Huiyin Yang,Zhanxiang Wang

DOI: https://doi.org/10.3389/fmed.2023.1244638

IF: 3.9

2023-01-01

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.939776.].
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Ya-Nan Pi,Wen-Cai Qi,Bai-Rong Xia,Ge Lou,Wei-Lin Jin

DOI: https://doi.org/10.3389/fimmu.2022.891942

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.697083.].
Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis

Xiaoqiang Liu,Zhengtao Zhou,Yibing Wang,Ke Zhu,Wen Deng,Yulei Li,Xiaochen Zhou,Luyao Chen,Yu Li,An Xie,Tao Zeng,Gongxian Wang,Bin Fu

DOI: https://doi.org/10.3389/fonc.2020.01735

IF: 4.7

2020-09-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00589.].

oncology

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression

Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Corrigendum: Cuproptosis Key Gene FDX1 is a Prognostic Biomarker and Associated with Immune Infiltration in Glioma.

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis